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Coronary venous injections of sonicated Renografin-76
were performed in seven closed chest dogs during two-
dimensional echocardiography to study the ability of this
new technique to opacify regional myocardium before
and after occlusion of the left anterior descending cor-
onary artery. The balloon of a 4F double lumen catheter
was inflated in the great cardiac vein for each contrast
injection to prevent backflow through the coronary sinus
into the right atrium. Retrograde injections before cor-
onary artery occlusion generally resulted in patchy myo-
cardial contrast uptake. Injections after coronary occlu-
sion always resulted in confluent and transmural myo-
cardial opacification which occupied 42.8 ± 8.6%
(range 26 to 54) (mean ± standard deviation) of the
myocardial circumference. Retrograde opacification al-
ways extended into adjacent myocardium beyond the
ischemic zone, which was assessed in echocardiograms
with antegrade contrast injections into the left main cor-
onary artery and which measured 30 ± 6.3% of the
ventricular circumference.
* This Seminar will appear on a continuing basis in succeeding issues
of the Journal. Part I appeared in the January 1984 issue. Part II in the
April 1984 issue, Part III in the May 1984 issue and Part IV in the July
1984 issue.
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Shunting from the coronary venous system to cardiac
chambers was evaluated in a parasternal four chamber
view and was graded on a scale of 0 to 4+. Contrast
appearance was equally intense in the right atrium and
right ventricle (3.5 ± 0.6 +, range 2+ to 4 +), less
intense in the left ventricular cavity (1.5 ± 0.6+, range
1+ to 3 +) and absent in the left atrium. Postmortem
anatomic validation with retrograde great cardiac vein
injections of indocyanine green corroborated the in vivo
contrast appearance in chambers.
Retrograde coronary venous contrast echocardiog-
raphy appears capable of providing in vivo information
about the extent and location of myocardial zones that
can be reached by retrograde infusions of therapeutic
agents and about the ability of these agents to reach
ischemic myocardium. In addition, this new method al-
lows for in vivo evaluation of shunts between coronary
veins and cardiac chambers, which may influence the
efficacy of retrograde interventions.
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Increasing attention is being paid to the coronary venous
system as a promising alternate route for delivery of a variety
of therapeutic interventions to the myocardium . Synchro-
nized retroperfusion with arterial blood (I), as well as in-
termittent occlusion of the coronary sinus (2, 3), appears
capable of decreasing infarct size in the setting of experi-
mental coronary occlusion. Initial experiences with retro-
grade application of streptokinase (4), antiarrhythmic agents
(5) and hypothermic cardioplegic solutions (6) also appear
promising and may have advantages over antegrade appli-
cation by means of the arterial pathway. Nevertheless, com-
pared with our knowledge about the coronary artery system,
the anatomy and physiology of the cardiac veins remain less
well defined. Only little is known about the location and
extent to which a specific vein subserves a myocardial zone
and whether it can, therefore, be used to apply a selective
retrograde intervention to this region.
It is also necessary to elucidate the variability and sig-
nificance of coronary veno-venous shunts, as well as of
direct connections between the coronary veins and cardiac
chambers. The existence of such interconnections has been
well documented, and it appears likely that any retrograde
injection will result in some direct leakage into cardiac
chambers, thereby diminishing the fraction of injectate that
might reach the myocardial microcirculation. Furthermore,
the extent to which retrograde coronary venous infusions of
arterial blood or drugs actually penetrate into regions of
ischemic myocardium is not well established.
Since the ability of contrast echocardiography to map
coronary arterial perfusion beds and delineate myocardial
perfusion defects after experimental coronary artery occlu-
sions has recently been demonstrated (7,8), we utilized this
method for in vivo study of the coronary venous system in
a canine model. The purpose of our work was to: 1) evaluate
the ability of retrograde coronary venous contrast injections
to penetrate regions of myocardium during the control state
and after coronary artery occlusion; 2) study the extent and
location of retrogradely induced myocardial contrast opa-
cification in relation to alternately delineated perfusion de-
fects; and 3) examine shunting from the coronary venous
system into cardiac chambers .
Methods
Experimental preparation. We studied seven dogs
weighing 25.8 ± 4.2 kg (range 21 to 33). The dogs were
premedicated with morphine sulfate (1.5 mg/kg intramus-
cularly) and anesthetized with sodium pentobarbital (30 mg/
kg intravenously) . Ventilation was performed with room air
using a Harvard respirator and a cuffed endotracheal tube.
Under fluoroscopic control, a 4F double lumen balloon cath-
eter was placed in the coronary sinus by way of the left
jugular vein and advanced to the great cardiac vein. A 9F
angiographic catheter was inserted into the left carotid artery
and positioned in the aortic root for monitoring of arterial
pressure. This catheter was also subsequently used for con-
trast injections into the left main coronary artery and to pass
a 2F balloon catheter into the left anterior descending cor-
onary artery for the purpose of intracoronary balloon oc-
clusion.
Echocardiographic imaging. Two-dimensional echo-
cardiographic studies were performed using a 90° mechan-
ical sector scanner equipped with a 3 MHz transducer . The
studies were performed as previously described (9) with the
dog on its right side and the transducer placed on the right
chest wall, pointing upward . Gain settings were individually
adjusted at the beginning of each study and not changed
throughout its course. Two-dimensional echocardiographic
images of the left ventricle were thus obtained in long-axis
as well as a short-axis cross-sectional plane at the low pap-
illary muscle level, and recorded on 1/2 inch (1.27 em)
videotape for subsequent analysis .
Contrast studies. Renografin-76 , which was sonicated
as previously described (10), served as the contrast agent
for both fluoro scopic and two-dimensional echocardi-
ographic studies; microbubbles produced by this method in
this particular agent have been shown to measure 10 ± 4
j.L. All echo contrast injections were performed using si-
multaneous fluoroscopic verification. Two injection sites
were used in all studies:
I) Antegrade injections of 2 ml of sonicated echo contrast
material were performed selectively into the left main cor-
onary artery through the 9F angiographic catheter. These
injections were carried out during the control state and after
balloon occlusion of the left anterior descending coronary
artery. Simultaneous fluoroscopy was used to ascertain that
both the left anterior descending and circumflex coronary
branches were injected simultaneously . This approach was
felt to be necessary to avoid accidental subselective injec-
tions, which can occur in the dog model because of the
shortness of the left main coronary artery.
2) Retrograde injections were performed into the great
cardiac vein through the 4F double lumen balloon catheter.
For this purpose , we inflated the balloon with 0.5 to I ml
of Renografin-76 to achieve occlusion of the coronary vein,
and then injected 5 ml of echo contrast material through the
center lumen of the catheter over a period of approximately
5 seconds. The balloon was deflated 10 seconds after ter-
mination of the injection. Simultaneous fluoroscopy was
utilized to assure that the balloon was firmly wedged and
that there was no leakage of contrast material to the coronary
sinus. All injections were performed by the same investi-
gator, using approximately the same injection force.
Experimental protocol. After catheter insertion and
stabilization of the dog's hemodynamic state, baseline echo-
cardiographic images were recorded . Two ml of echo con-
trast agent were then injected into the left main coronary
artery to document that no perfusion defect was present
during the control state. To study the ability of retrograde
contrast injections to opacify myocardium in the absence of
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A) LAD OCCLUSION BEFORE CONTRAST
B) LMCA CONTRAST INJECTION
/
Reltogade ooacdication ( : SOl
Figure 2. Extent and relation of antegrade perfusion defect and
retrograde myocardial opacification in seven dogs. AP = anterior
papillary muscle; PP = posterior papillary muscle.
to delineate the underperfused zone. Contrast injections into
the great cardiac vein were then performed during left an-
terior descending coronary artery occlusion in the manner
described for the control state.
Image analysis. Contrast injections into the left main
coronary artery and the great cardiac vein were analyzed
from end-diastolic freeze frame images of the left ventricular
cross section. A transparent plastic foil was placed on the
video screen and endocardial and epicardial outlines as well
as the borders between zones with and without contrast
uptake were traced using a grease pencil. The chosen edge
delineation was reviewed during slow and fast dynamic
replay of the videotape. The obtained drawings were then
retraced on a digitizing tablet. The center of gravity of the
epicardial outline was determined by a computer, and lines
were drawn between it and the borders of contrast uptake.
The resulting angle, which reflected the circumferential ex-
tent of the myocardial zone, was measured and expressed
as a percent of left ventricular circumference of the echo-
graphic cross section.
To compare the extents of myocardial opacification ob-
tained with the first and second retrograde injections, the
mean percent error of the measurement was calculated using
the formula:
/
Figure 1. Antegrade and retrograde echocardiographic contrast
studies after occlusion of the left anterior descending (LAD) cor-
onary artery. A, Baseline image before contrast injection. B, In-
jection into the left main coronary artery (LMCA) results in myo-
cardial opacification with a filling defect in the underperfused
region (approximately 8 to 10 o'clock). The diminished contrast
intensity adjacent to the posteromedial papillary muscle (approx-
imately 2 to 4 o'clock) is due to echo dropout, which is most
likely caused by lung interference. C, Retrograde great cardiac
vein (GCV) contrast injection results in transmural myocardial
opacification of the underperfused zone as well as of adjacent
myocardium (approximately 5 to 11 o'clock). Contrast can also
be noted Within the left ventricular cavity.
C) GCV CONTRAST INJECTION
/
coronary artery occlusion, we inflated the balloon within
the great cardiac vein and hand-injected 5 ml of echo con-
trast material over a period of 5 seconds. The balloon was
deflated 10 seconds after injection.
The left anterior descending coronary artery was then
occluded below the first septal branch by threading a 2F
balloon catheter through the 9F angiographic catheter and
inflating the balloon with 0.5 to 1 ml of Renografin. Ten
to 15 minutes after coronary occlusion, we repeated the left
main coronary artery injections of the echo contrast agent
Mean % error = [A(max) - A(mean») X 100
A(mean)
where A(max) represents the larger angle and A(mean) the
average of the two angle measurements.
The magnitude ofdirect shunting from the coronary ve-
nous circulation to cardiac chambers in parasternal four
chamber planes was evaluated semiquantitatively by two
blinded observers who graded the appearance of contrast
580 MAURER ET AL.
CORONARY VENOUS CONTRAST ECHOCARDIOGRAPHY
Table 1. Myocardial Delineation After Left Anterior Descending Coronary Artery Occlusion:
Extent of Contrast Filling Defect With Left Main Coronary Artery Injection Versus Myocardial
Opacification After Retrograde Great Cardiac Vein Injection
Retrograde
Antegrade
Opacification
Dog Defect Injection I Injection 2 Mean
I 34 33 48 40.5
2 37 50 36 43
3 21 54 51 52.5
4 36 48 50 49
5 32 46 48 47
6 26 41 42 41.5
7 24 26 26
Mean 30 42.8
± SD ± 6.3 ± 8.6
Values represent percentof left ventricular short-axis cross-sectional circumference.
lACC Vol. 4, No.3
September 1984:577-86
within the chamber on a scale of 0 to 4 +, where 0 = no
contrast, 1+ = few isolated bubbles seen in chamber, 2 +
= numerous bubbles without confluescence, 3 + = nu-
merous bubbles with areas of confluescence opacifying por-
tions of the chamber and 4 + = contrast opacification of
the whole chamber.
Anatomic validation of shunting. After termination of
echocontrast studies, the dog was killed by intravenous in-
jection of potassium chloride. In three dogs, the heart was
excised and used for anatomic validation of the shunt
studies. After opening both atria, the 4F double lumen bal-
loon catheter was reinserted into the coronary sinus and
Figure 3. Retrograde coronary venous contrast injections without
coronary artery occlusion. A, Baseline image. B, Great cardiac
vein injection results in patchy myocardial opacification. The
bright rounded structures (arrows) presumably represent epicardial
coronary veins containing contrast material. C, Coronary sinus
injection also results in patchy but more extensive myocardial
opacification which now also involves the posterior papillary
muscle.
advanced to the great cardiac vein. The balloon was then
inflated so that the catheter was firmly wedged within the
vessel. Indocyanine green was injected in 1 ml increments
and both atria were inspected for evidence of leakage of
dye. In addition, both ventricles were inspected through the
atrioventricular valves. For better visualization of the en-
docardial surface, both ventricles were then carefully cut
open with single incisions into the free walls, starting from
the apexes. The atrioventricular rings were left intact. Great
care was used to avoid damaging any of the visible epicardial
veins. The heart was then washed with tap water, and dye
injection into the great cardiac vein was repeated as de-
scribed.
Results
Antegrade left main coronary artery injections.
During the control state, injections of echo contrast material
into the left main coronary artery always resulted in two-
dimensional echocardiographic opacification of the entire
left ventricular short-axis cross section. After occlusion of
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Table 2. Type of Myocardial Opacification With Contrast
Injection Into the Great Cardiac Vein
the left anteriordescendingbranch, left maincoronaryartery
injections always resulted in a well defined contrast filling
defect in the region of the anterior wall (Fig. 1 and 2),
frequently also involvinga portionof the ventricularseptum.
The defect involved 30 ± 6.3% (range 21 to 37) (mean ±
standard deviation) of the left ventricular short-axis section
circumference (Table 1).
Retrograde coronary venous injections. Before cor-
onary artery occlusion, injections into the great cardiac vein
(Fig. 3, Table 2) frequentlyresulted in patchy nontransmural
myocardial opacification or (in two instances) in no opa-
cification at all. After occlusion, the retrograde injections
always resulted in confluentand transmuralmyocardialopa-
cification (Fig. 1, Table 2).
Extent of myocardial opacification after coronary ar-
tery occlusion. Contrast injections into the great cardiac
vein opacified not only the entire region of the fillingdefect
that had been observed with the antegrade injection, but
almost always also extended into adjacentmyocardium(Fig.
1 and 2). The myocardial zone of retrograde uptake of
contrast material involved 42.8 ± 8.6% (range 26 to 54)
(mean ± standard deviation) of the left ventricular short-
axis section circumference (Table 1). Mean injection to
injection measurement error of this retrogradely delineated
myocardial zone in six dogs was 7.2 ± 8.0%. In a seventh
dog, the second retrograde injection could not be performed
because the balloon on the coronary sinus catheter was ac-
cidentally damaged by overinflation.
Shunting from coronary veins to cardiac chambers.
Every coronary venous injection was associated with the
appearance of echo contrast in both left and right cardiac
chambers. Simultaneous fluoroscopy confirmed complete
balloon occlusion of the coronary vein and, thus, excluded
direct coronary sinus backflow into the right atrium as a
cause for this contrast appearance.
In five of the dogs, we performed coronary venous con-
trast injectionsduring the control state while recordingecho-
cardiographic parasternal four chamber views. Immediately
Dog
Injections
Before LAD Occlusion
2
Injections
After LAD Occlusion
2
after the retrograde injection, contrast was seen in the right
atrial and ventricular chambers, followed almost instanta-
neously by appearance within the left ventricular myocar-
dium and cavity (Fig. 4 and 5). Myocardial opacification
C = confluent transmural opacification; LAD = left anterior de-
scending coronary artery; 0 = no myocardial opacification; P = patchy
nontransmural opacification.
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Figure 4. Top, Parasternal four chamber view during control
state. Middle, Injection into the great cardiac vein results in the
appearance of bright contrast in the right atrium (RA) and right
ventricle (RV). Bottom, Several cardiac cycles later, thecontrast
in the right side of the heart has disappeared; a small amount of
contrast material isstill seen within theleftventricular (LV) cavity,
butnotwithin the leftatrium (LA). Although opacification of left
ventricular myocardium hadbeen obvious on short-axis views, no
such effect can be seen in the long-axis view because the echo-
cardiographic plane fails to transsect the area of myocardial con-
trast uptake.
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Figure 5. Parasternal four chamber view. Top, Control state.
Bottom, In this particular dog, contrast injection results in exten-
sive left ventricular (LV) myocardial opacification involving the
ventricular septum, apex and a portion of the posterior wall. Ab-
breviations as in Figure 4.
was frequently less extensive than in the short-axis views
and was occasionally absent, presumably because the im-
aging plane often failed to transsect the zone of contrast
uptake. In four dogs, we were able to visualize at least one
of the sources of left ventricular chamber contrast; a contrast
jet was observed to originate near the base of the anterior
papillary muscle and quickly dispersed within the chamber
(Fig. 6).
Semiquantitative evaluation of coronary vein to
cardiac chamber shunting (Table 3). The appearance of
contrast was most intense in the right atrium and right ven-
tricle and was graded as 3.5 ± 0.6 + (range 2 to 4 +) for
individual injections. Both of these chambers were always
graded identically. Contrast within the left ventricle was
less intense and was scored as 1.5 ± 0.6 + (range 1 to
Figure 6. Time sequence of short-axis images at the low papillary
muscle level. A, Control state. B through F, Contrast injection
into the great cardiac vein. In addition to myocardial opacification
(approximately 7 to 12 o'clock), there is passage of contrast ma-
terial into the left ventricular cavity near the base of the anterior
papillary muscle (arrow in B), resulting in a contrast jet (C
through E) which finally breaks up and disperses (F).
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Table 3. Intracavitary Contrast Appearance After Great Cardiac
Vein Injections
Oog LA LV RA RV
1 0 1 3.5 3.5
2 0 2.5 3.5 3.5
3 0 1 2.5 2.5
4 0 1.5 4 4
5 0 1.5 4 4
Mean ± SO 0 1.5 ± 0.6 3.5 ± 0.6 3.5 ± 0.6
Averages tor two injections are given. LA = left atrium; LV = left
ventricle; RA = right atrium; RV = right ventricle; SO = standard
deviation.
3 +). In no instance could we detect the appearance of
contrast in the left atrial cavity,
The interobserver and interinjection agreement for the
scoring of intracavitary contrast intensity is illustrated in
Tables 4 and 5. Discrepancies never exceeded one grading
step and predominantly occurred between grades 2 + and
3+.
Anatomic validation. Postmortem injections of indo-
cyanine green into the great cardiac vein resulted in the
appearance of dye in the orifices of venous branches draining
into the coronary sinus near its atrial junction, as well as
in several places on the endocardial surface of the right
atrial free wall. Although we could also observe some dye
appearing on the inner surface of the left atrial free wall, it
seemed to occur to a lesser degree and only after a larger
volume of injectate. In the right ventricular cavity, dye
appeared between trabeculations near the apical region, as
well as from multiple small foramina that were located just
below the tricuspid valve (Fig. 7, top). In the left ventricular
cavity, leakage of dye was most prominent from a single
small orifice located near the base of the anterior papillary
muscle (Fig. 7, bottom).
Discussion
Retrograde myocardial contrast opacifiacition. Echo-
cardiographic myocardial opacification by means of retro-
grade coronary venous injections of contrast agent has not
been previously described. Using our new methodology, we
were able to demonstrate this phenomenon in each of our
laboratory animals. After occlusion of the left anterior de-
Table4. Interobserver Agreement for Contrast Intensity in
Individual Cardiac Chambers
Observer 1
0 1+ 2+ 3+ 4+
Observer 2
0 10
1+ 6
2+ 3 3
3+ 1 5 1
4+ II
Table5. Interinjection Agreement for Contrast Intensity in
Individual Cardiac Chambers
Injection 1
0 1+ 2+ 3+ 4+
Injection 2
0 5
l+ 2 2
2+
3+ 2 2
4+ 2 4
scending coronary artery, transmural and confluent opaci-
fication of a myocardial zone could be achieved with every
single retrograde coronary venous injection, however, be-
fore the occlusion we frequently only obtained patchy non-
transmural opacification, and with two injections no opaci-
fication was seen. The latter differences may be due to the
difficulty of retrograde injection against full antegrade blood
flow in the presence of normal coronary arteries. Our results
are in support of previous studies that noted preferential
flow to the ischemic area as compared with the normally
perfused myocardium with retrograde injections of krypton-
85 (11) or when delivering radioactive microspheres by
means of synchronized retroperfusion (12). After coronary
occlusion, retrograde contrast injections opacified not only
the underperfused zone, but also the adjacent myocardium.
The zone of myocardial contrast uptake never occupied more
than roughly half of the left ventricular circumference as
seen on two-dimensional echocardiographic short-axis cross
sections at the low papillary muscle level, and was always
located in the region of the anterior wall and the adjacent
portions of the ventricular septum and lateral wall (Fig. 1
and 2). Great cardiac vein injections never resulted in
opacification of the posterior or inferior walls or of the
inferior part of the septum.
Thus, the outlined area probably represents mostly the
anatomic distribution of the anterior interventricular veins
which accompany the left anterior descending coronary ar-
tery, and perhaps that of other distal branches of the great
cardiac vein (13-16). The location of the intravenous oc-
cluding balloon did not permit access to the posterior left
ventricular vein, which usually runs along the obtuse margin
of the heart. Another of the larger branches, the middle
cardiac vein, which is located in the posterior interventric-
ular sulcus, usually drains into the very proximal coronary
sinus. To be accessible for retrograde injections, this vessel
would, therefore, probably require selective cannulation be-
cause its orifice would usually be occluded by a balloon
catheter positioned near the beginning of the coronary sinus.
The same is most likely true for the small cardiac vein,
which runs along the atrioventricular groove between the
right atrium and ventricle and also drains into the proximal
coronary sinus.
Thus, our preliminary observations suggest that retro-
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Figure 7. Postmortem specimens after retrograde
great cardiac vein injection of indocyanine green.
Top, Right ventricle. Injection results in appearance
of dye at the endocardial surface of the right ven-
tricle from small foramina below the tricuspid valve
(top arrow), as well as between trabeculations
(bottom right arrow). Bottom, Leftventricle (same
dog as in Fig. 6). Injection results in appearance of
dye from an orifice at the base of the papillary
muscle (arrow).
grade penetration of contrast material into the myocardium
appears to be affected by at least two factors: anatomic
distribution of the vessels distal to the catheter tip and mag-
nitude of arterial blood flow to the myocardial zone. These
factors may also account for the greater extent of retrograde
opacification as compared with the antegrade filling defect,
although the exact mechanisms are currently not well un-
derstood.
Additional studies are needed to further investigate these
hypotheses . Injections into the proximal coronary sinus
should be compared with injections into the great cardiac
vein and subselectively cannulated smaller branches. Pre-
liminary evidence suggests that the extent of myocardial
opacification achieved from the coronary sinus is greater
(Fig. 3) than from the great cardiac vein, although still not
involving the entire left ventricular circumference. Further
experiments in the presence of circumflex coronary artery
occlusion should help to evaluate the degree of affinity of
retrograde injections for ischemic myocardium, as well as
to clarify the possible role of coronary veno-venous shunts.
Computer videodensitometry (17) may be helpful to assess
differences in contrast intensity within the opacified region
as well as their time course , and may thus offer quantitative
information on perfusion beyond mere delineation.
Shunting to cardiac chambers. Direct connections be-
tween the coronary venous system and cardiac chambers
were described by Thebesius in 1716 (18). With the appli-
cation of newer interventions employing the coronary ve-
nous system as an alternate pathway to reach jeopardized
myocardium (1-6) , these thebesian connections might have
a new and previously not appreciated significance because
they could cause direct leakage of a currently unknown
fraction of the injectate into the cardiac chambers. A pre-
vious study (19), using an isolated perfused dog heart prep-
JACC VI'I. 4, No.3
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aratiom demonstrated that augmentation of coronary sinus
pressure resulted in a marked increase in direct shunting
into the right and to a lesser degree the left cardiac chambers.
When coronary sinus pressure approached 35 to 40 mm Hg,
drainage through the coronary sinus stopped completely and
approximately 85% of coronary venous outflow passed di-
rectly to the right heart chambers, while the remaining 15%
drained into the left heart chambers. The study did not
attempt to differentiate between atrial and ventricular
drainage.
Ouc findings with retrograde echo contrast injections in
vivo and indocyanine green dye injections postmortem must
be considered only semiquantitative, but they also suggest
the presence of significant direct drainage into the right side
of the heart and a lesser degree of drainage into the left side
of the heart. With the methodology we used, in vivo dif-
ferentiation between direct right atrial and right ventricular
outflow is difficult, although such differentiation might be
possible in the future using a smaller amount of injectate
and frame by frame analysis. On the left side, however, it
appears that most of the in vivo drainage occurs directly
into the left ventricle since we were never able to observe
any contrast effect within the left atrium. Computer video-
densitometry within each of the cardiac chambers may offer
additional insights in the relative magnitude of flow into
each of the cavities.
Limitations of study. A major limitation of our prelim-
inary study is that we performed injections manually without
actually measuring injection pressure, although all studies
were performed by the same investigator, who consciously
attempted to always apply the same injection force. Further
experiments are needed to carefully study the role of dif-
ferent mjection pressures and volumes. As mentioned ear-
lier, there is also a need to evaluate injections into the
proximal coronary sinus and venous branches and to also
study myocardial opacification in the setting of circumflex
coronary artery occlusion. Our comparison of myocardial
contrast with and without coronary artery occlusion and the
evaluation of contrast appearance in cardiac chambers are
only subjective and could be improved by the use of com-
puter videodensitometric methods. Furthermore, we do not
have any information on whether the coronary venous con-
trast injections actually resulted in penetration into the mi-
crocirculation or merely outlined the distribution of larger
intramural veins. Validations with other, more established
methods, such as radioactive microspheres, should help to
answer some of our questions.
Significance and potential implications. Retrograde
coronary venous contrast echocardiography could contribute
to our understanding of cardiac anatomy and physiology by
allowng for in vivo identification of zones of myocardium
that are subserved by individual veins and by offering in-
formr.tion about connections between veins and cardiac
chambers, In addition, it may serve as an investigational
tool that could aid our understanding of retroperfusion, in-
termittent coronary sinus occlusion as well as retrograde
drug infusions by identifying regions of myocardium that
can be reached by these interventions and by establishing
their relation to the ischemic zone. An additional potential
application could be the retrograde delivery of a myocardial
echo contrast agent into ischemic regions for evaluation of
myocardial blood flow by means of echo contrast
"washout" analysis (17). Further studies should offer ad-
ditional insights regarding applicability and usefulness of
this new methodology.
References
I. Meerbaum S, Haendchen RV, Corday E, et al. Hypothermic coronary
venous phased retroperfusion: a closed-chest treatment of acute re-
gional myocardial ischemia. Circulation 1982;65:1435-45.
2. Mohl W, Heimisch W, Aigner A, Glogar D, Wolner E. Improvement
of regional cardiac function by intermittent coronary sinus occlusion
(abstr). Circulation 1983;68(suppl III):III-186.
3. Mohl W, Glogar D, Mayr H, et al. Reduction of infarct size induced
by pressure controlled intermittent coronary sinus occlusion. Am J
Cardiol 1984;53:923-8.
4. Meerbaum S, Lang TW, Povzhitkov M, et al. Retrograde lysis of
coronary artery thrombus by coronary venous streptokinase admin-
istration. J Am Coli Cardiol 1983;1:1262-7.
5. Karageuzian HS, Ohta M, Drury JK, et al. Comparative efficacy of
intravenous and coronary venous retroinfusion of procainamide for
the management of inducible sustained ventricular tachycardia in con-
scious dogs during chronic myocardial infarction. In: Mohl W, ed.
The Coronary Sinus. Darmstadt, FGR: Steinkopff Verlag (in press).
6. Menasche P, Kural S, Fauchet M, et al. Retrograde coronary sinus
perfusion: a safe alternative for ensuring cardioplegic delivery in aortic
valve surgery. Ann Thorac Surg 1982;34:647-59.
7. Sakamaki T, Tei C, Meerbaum S, et al. Verification of myocardial
contrast two-dimensional echocardiographic assessment of perfusion
defects in ischemic myocardium. J Am Coli Cardiol 1984;3:34-8.
8. Tei C, Sakamaki T, Shah PM, et al. Myocardial contrast echocardi-
ography: a reproducible technique of myocardial opacification for iden-
tifying regional perfusion defects. Circulation 1983;67:585-93.
9. Wyatt HL, Heng MK, Meerbaum S, et al. Cross-sectional echocar-
diography. I. Analysis of mathematical models for quantifying the
mass of the left ventricle in dogs. Circulation 1979;60:1104-13.
10. Feinstein SB, Ten Cate FJ, Zwehl W, et al. Two-dimensional contrast
echocardiography. I. In vitro development and quantitative analysis
of echo contrast agents. J Am Coli Cardiol 1984;3:14-20.
II. Cibulski AA, Markov A, Lehan PH, et al. Retrograde radioisotope
myocardial perfusion patterns in dogs. Circulation 1974;50:159-66.
12. Berdeaux A, Farcot JC, Bourdarias JP, Barry M, Bardet J, Giudicelli
JF. Effects of diastolic synchronized retroperfusion on regional cor-
onary blood flow in experimental myocardial ischemia. Am J Cardiol
1981;47:1033-40.
13. Evans HE, Christensen Gc. Blood vessels of the heart. In: Miller's
Anatomy of the Dog. Philadelphia: WB Saunders, 1979:647-51.
14. Gensini GG, Di Giorgi S, Coskun 0, Palacio A, Kelly AE. Anatomy
of the coronary circulation in living man: coronary venography. Cir-
culation 1965;31:778-84.
15. Hood WB. Regional venous drainage of the human heart. Br Heart J
1968;30: 105-9.
16. Barry A, Patten B. The structure of the adult heart. In: Gould SE,
586 MAURER ET AL.
CORONARY VENOUS CONTRAST ECHOCARDIOGRAPHY
lACC Vol. 4. No. 3
September 1%4:577- 86
cd. Pathology of the Heart. Springfield, IL: Charles C Thomas, 1960:93-
130 .
17. Maurer G, Ong K, Haendchen R, er at. Myocard ial contrast two-
dimensional echocardiography: compari son of contrast disappearanc e
rates in normal and und erper fu sed myocardium. Circulation
1984;69:418-29.
18. Thebesius AC. Dissertatio medica de circulo sanguinis in corde. Lug-
duni Batavorum apud Joh . Arnold . Langerak: 1716:31.
19. Scharf SS, Brombcrger-Bamea B, Permutt S. Distribut ion of coronary
venous flow. J Appl Physiol 1971;30:657-62.
